קונבריזה

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

BAZEDOXIFENE AS ACETATE 20 MG

Tilgjengelig fra:

NEOPHARM LTD

ATC-kode:

G03XC02

Legemiddelform:

COATED TABLETS

Administreringsrute:

PER OS

Produsert av:

PFIZER IRELAND PHARMACEUTICALS

Terapeutisk gruppe:

BAZEDOXIFENE

Indikasjoner:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Autorisasjon dato:

2013-04-01